Smart Holograms

The objective of the grant, awarded to Smart and the University of Bath, is the research, development and implementation of novel glucose receptors for use in Sensor Holograms, the Company's pioneering diagnostic technology.

Dr. John Pritchard, Chief Technology Officer at Smart Holograms, said: "Tony James at Bath University is the leading expert in his field. His experience will be of invaluable to the development of our business and technology."

Dr. Tony James, Senior Lecturer in Organic Chemistry and Royal Society Research Fellow, at Bath University said: "My group have been working in this area for a number of years. Our collaboration with Smart, through a KTP associate, will be of enormous benefit to our ongoing research at the University of Bath."

KTP Programme Manager at the University of Bath, Richard Battams, said: "Knowledge Transfer Partnerships deliver huge benefits for the Company, University and Graduate employed. It is especially exciting for me to be involved in this project, which has the potential to benefit the large number of people that have to live with diabetes."

Smart Holograms is developing glucose sensors for minimally-invasive, continuous monitoring. The Sensor Hologram approach that Smart is pioneering is not only distinct from but has many clear advantages over competing technologies, including power-free function and low-cost, simple manufacture.

Furthermore, they are unaffected by environmental conditions, are made from the same materials as found in contact lenses and tissue implants and use synthetic receptors allowing them to be sterilised by conventional means and used in-vivo.





Smart Holograms is an early-stage company that has exclusive rights to the sensor hologram technology invented at Cambridge University. To date, Smart has had an investment of 17 million in its core science base and in the business. The Company currently has a team of 25 people (including 12 with PhDs) and has two facilities: in Cambridge (UK) and in San Ramon (USA).

Smart is also planning to open a new Commercial office in Boston later this year. In addition, it has four partnerships with global, leading companies for exploitation of its novel sensor hologram technology. The company is currently doubling its head count, tripling its facility space and aims to be completing development and manufacture of its first products in 2006.

John Pritchard PhD MBA (Chief Technical Officer) has over twenty years of international management experience from companies such as Boehringer Mannheim, Genzyme and Hypoguard. At Boehringer Mannheim he was responsible for the development of the first generation biosensor test strip for the Accuchek Advantage (TM) blood glucose monitoring system. He has a PhD in Biochemistry from Liverpool University and an MBA from Boston University. John joined Smart in November 2005.


*******

Further information:

Frank F. Craig PhD MBA, Smart Holograms, telephone: +44 (0)1223 393403, Info@SmartHolograms.com


Knowledge Transfer Partnerships: http://www.ktponline.org.uk/

Dr. Tony James: http://www.bath.ac.uk/chemistry/james



Media information:

Jane Heeney, Elements PR, telephone: +44 (0)1223 421605 info@elementspr.co.uk.